Alzheimer's Disease Related Funding Opportunities

 

Opportunity Number

Opportunity Title

Synopsis

Next deadline

NIH – R01 PAR-16-448

Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R01)

Basic research to characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease (AD)

June 5

October 5

NIH – R21 PAR-16-449

Basic and Translational Research on Decision Making in Aging and Alzheimer's Disease (R21)

Basic research to characterize the affective, cognitive, social, and motivational parameters of impaired and intact decision making in both normal aging and Alzheimer's disease (AD)

June 16

October 16

NIH Limited CompetitionPAR-17-020

Revision Requests for Active Alzheimer's Disease Research Centers (P50)

NIA invites Revision applications to ongoing NIA-supported Alzheimer's Disease Research Centers (P50) in order to expand the scope of the existing award. Revision applications may propose a new core, new project or changes to an existing core. Revision applications may not request support beyond the end date of the Parent P50 award

May 25

September 25

NIH Limited Competition - PAR-17-019

Revision Requests for Active Alzheimer's Disease Core Centers (P30)

NIA invites Revision applications to ongoing NIA-supported Alzheimer's Disease Core Centers (P30) in order to expand the scope of the existing award. Revision applications may propose a new core or changes to an existing core. Revision applications may not request support beyond the end date of the Parent P30 award.

May 25

September 25

NIH – R01 - PAR-17-029

Dynamic Interactions between Systemic or Non-Neuronal Systems and the Brain in Aging and in Alzheimers Disease (R01)

Support innovative multidisciplinary research that will integrate the AD science with the basic biology of aging and clinical aging research

June 5

October 5

NIH – R01 - PAS-17-027

Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R01)

Address clinical and translational research gaps in the study of end-of-life care needs in order to improve quality of life at the end of life of people with Alzheimer’s disease and related dementias (ADRD) and their families

June 5

October 5

NIH – R03 - PAS-17-026

Improving Quality of Care and Quality of Life for Persons with Alzheimers Disease and Related Dementias at the End of Life (R03)

Propose analysis of secondary data, to address clinical and translational gaps in the study of end-of-life care needs of people with Alzheimer's disease or related dementias (ADRD) and their families

June 16

October 16

NIH – R01 - PAR-17-038

Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R01)

Focus on clarifying the relationship between delirium and Alzheimer's disease and related dementias (ADRD).

June 5

October 5

NIH – R21/R33 - PAR-17-037

Clarifying the Relationship between Delirium and Alzheimers Disease and Related Dementias (R21/R33)

Use the R21/R33 phased innovation mechanism to conduct exploratory/developmental studies focused on feasibility or proof-of-concept that may then transition to an implementation phase following successful achievement of pre-defined investigator-proposed milestones.

June 16

October 16

NIH – R01 - PAR-15-349Health Disparities and Alzheimer's DiseaseResearch approaches of interest include 1) improving recruitment and retention of populations underrepresented in AD research, 2) identifying priority factors or locating pathways and mechanisms that create and sustain AD health disparities, 3) addressing the challenges faced by informal/family caregivers from diverse racial, ethnic and socioeconomic backgrounds that are associated with the growing population of individuals with Alzheimer’s Disease, and 4) understanding the disparities in access to and utilization of formal long-term supports and services for those with dementia.

June 5

October 5

NIH – R01 - PAR-17-031

Role of Age-Associated Metabolic Changes in Alzheimer's Disease (AD) (R01)

Innovative experimental approaches to explore the molecular and cellular bases for age-related change in metabolism that impact the development of Alzheimer's disease (AD).

June 5

October 5

NIH – R01 - PAR-17-047

Selective Cell and Network Vulnerability in Aging and Alzheimers Disease (R01)

Define and characterize neural cell populations, neural circuits, and brain networks and regions that are vulnerable to brain aging and Alzheimer’s disease (AD). Mechanisms underlying selective vulnerability from cells to networks in to fully define the disease process and to develop effective therapies.

June 5

October 5

NIH – R01 - PAR-17-032

Translational Bioinformatics Approaches to Advance Drug Repositioning and Combination Therapy Development for Alzheimers Disease (R01)

Integrate the use of computational approaches to identify individual drugs currently used for other conditions with potential to be efficacious in AD or AD-related dementias (as single drugs or as drug combinations) with proof-of-concept efficacy studies in cell-based models, animal models and/or humans. 

June 5

October 5

NIH – R21 - PAR-17-039

Comparative Biology of Neurodegeneration (R21)

Exploratory comparative biology research projects assessing how different animal species respond to challenges and damage to cellular physiology pathways that might influence the onset of Alzheimer's and other neurodegenerative diseases as well as resilience to them, such as adaptation to stress, macromolecular damage, proteostasis and stem cell function and regeneration.

June 16

October 16

For NIH R41/R42 and R43/R44, please see the NACS SBIR/STTR funding page  

April 5 

September 5